| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8846 |
| Human Intestinal Absorption | HIA+ | 0.9926 |
| Caco-2 Permeability | Caco2+ | 0.8955 |
| P-glycoprotein Substrate | Non-substrate | 0.6744 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7884 |
| Non-inhibitor | 0.7923 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8863 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8831 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8055 |
| CYP450 2D6 Substrate | Non-substrate | 0.7272 |
| CYP450 3A4 Substrate | Non-substrate | 0.6247 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5460 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9090 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8470 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5499 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9486 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6257 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9146 |
| Non-inhibitor | 0.8746 |
| AMES Toxicity | Non AMES toxic | 0.9497 |
| Carcinogens | Non-carcinogens | 0.7816 |
| Fish Toxicity | High FHMT | 0.5540 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8543 |
| Honey Bee Toxicity | High HBT | 0.8026 |
| Biodegradation | Ready biodegradable | 0.5186 |
| Acute Oral Toxicity | III | 0.8831 |
| Carcinogenicity (Three-class) | Non-required | 0.5518 |